Gilliland Jeter Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-11,708
Closed -$1.52M – 176
2025
Q2
$1.52M Sell
11,708
-1,000
-8% -$145K 0.49% 47
2025
Q1
$2.02M Sell
12,708
-15
-0.1% -$2.71K 0.72% 40
2024
Q4
$2.36M Sell
12,723
-100
-0.8% -$19.4K 0.8% 34
2024
Q3
$2.71M Sell
12,823
-2,685
-17% -$466K 0.87% 27
2024
Q2
$2.08M Buy
15,508
+125
+0.8% +$23.7K 0.7% 38
2024
Q1
$3.3M Sell
15,383
-1,180
-7% -$231K 1.15% 20
2023
Q4
$3.37M Buy
+16,563
New +$2.68M 1.39% 15

Other funds holding INSP

Gilliland Jeter Wealth Management's INSP Position: Q3 2025 in Review

Gilliland Jeter Wealth Management sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 11,708 shares — an estimated $1.52M sold.

Gilliland Jeter Wealth Management first reported a position in INSP in Q4 2023 and held it in 7 quarters. The position peaked at $3.37M in Q4 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Gilliland Jeter Wealth Management reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 11,708 Inspire Medical Systems shares in Q3 2025, an estimated $1.52M.
  • Gilliland Jeter Wealth Management first reported a position in Inspire Medical Systems in Q4 2023 and held it in 7 quarters.
  • Gilliland Jeter Wealth Management's Inspire Medical Systems position peaked at $3.37M in Q4 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Gilliland Jeter Wealth Management's 13F filing for Q3 2025, filed 28 Oct 2025.